Additionally, signals from tumor-delivered VEGF led to the upregulation of 6-phosphofructo-2-kinase/fructose-2,6-biphosphatase 3 (PFKFB3) in endothelial cells, activating PFK-1, further intensifying the glycolytic phenotype [64]. This evidence concerns the gene PFKFB3 and neoplasm.